Health Catalyst, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Health Catalyst, Inc. on August 4, 2022, reporting an event that occurred on August 2, 2022. The filing discloses the authorization of a new share repurchase program by the Company's board of directors.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, or debt figures. The primary financial metric disclosed is the authorization of a share repurchase program with a total value of up to $40 million of the Company's outstanding common stock.
Material Changes
The material change reported is the initiation of the share repurchase program. The Company stated it expects to fund these repurchases using existing cash and cash equivalents, working capital, cash flow from operations, or funds available through various borrowing arrangements. The program does not obligate the Company to acquire any specific amount of stock and may be modified, suspended, or terminated at any time.
Guidance, Outlook, and Risks
Management indicated that the timing and amount of repurchases will be determined at their discretion based on market conditions and corporate needs. The filing includes standard forward-looking statement disclaimers, noting that actual results may differ due to factors such as stock price volatility, market conditions, and capital investment requirements. The Company does not intend to update these forward-looking statements.
Investor Verification Checklist
- Verify the current market price of Health Catalyst common stock (HCAT) to assess the potential number of shares purchasable under the $40 million authorization.
- Review the Company's most recent Form 10-K or 10-Q to confirm the availability of cash, cash equivalents, and working capital to fund the repurchases.
- Monitor future filings for updates on the actual execution of the repurchase program, including the number of shares purchased and average price paid.
- Check for any subsequent announcements regarding the suspension, modification, or termination of the program.